SenesTech’s stock rose 4.6% after the company reported growth in its direct-to-consumer and subscription revenues following key strategic shifts, notably the in-house management of its Amazon channel that improved control and advertising efficiency.
SenesTech reported a strong third quarter for fiscal year 2025, achieving record revenues with a 43% year-over-year increase, driven by the rapid adoption of its Evolve product line and strategic retail partnerships.
SenesTech reported a remarkable second quarter for FY 2025, achieving record revenues and gross profit margins driven by a 94% year-over-year increase in sales of its Evolve Rodent Birth Control solution.